Table 3. Predictors for non-being referred for HCV therapy consideration (n = 562) in unadjusted and adjusted analyses.

Covariate	Unadjusted OR (95% CI)	P value	Adjusted OR (95% CI)	P value
Not engage in care	5.08 (3.24–6.97)	<0.000001	4.42 (2.69–7.28)	<0.000001
Having detectable HIV load* (>40 copies/mL)	1.98 (1.36–2.75)	0.0001	1.88 (1.26–2.81)	0.002
Unstable housing	2.26 (1.30–3.93)	0.004	1.97 (1.03–3.79)	0.041
Having an active malignancy	3.47 (1.35–8.92)	0.01	2.78 (0.96–8.03)	0.058
AIDS (CD4 cell count <200/mm3)	1.83 (1.22–2.75)	0.004	1.68 (1.05–2.69)	0.030
Non-white race	1.67 (1.17–2.38)	0.005	1.59 (1.06–2.40)	0.025
HIV risk factors (reference intravenous drug use)
Men having sex with men	1.96 (1.34–2.87)	0.0006	1.96 (1.27–3.02)	0.0023
Other	2.51(1.54–4.07)	0.0002	1.64 (0.95–2.82)	0.075
Ongoing neuropsychiatry condition	0.35 (0.26–0.63)	<0.000001	0.37 (0.24–0.56)	<0.000001
Ongoing drug and/or alcohol abuse	0.64 (0.45–0.91)	0.013	0.52 (0.34 –0.80)	0.0027

*Two patients in the HCV non-referred group without available HIV viral loads were removed from final analyses.